OLOPATADINE/TU - Search Results

Year	Number of Results
2014	2
2015	5
2016	10
2017	6
2018	9
2019	11
2020	7
2021	3
2022	4
2023	7
2024	4
2025	0

1

Bernstein JA, Bernstein JS, Makol R, Ward S. Bernstein JA, et al. JAMA. 2024 Mar 12;331(10):866-877. doi: 10.1001/jama.2024.0530. JAMA. 2024. PMID: 38470381 Review.

2

Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis.

Kam KW, Chen LJ, Wat N, Young AL. Kam KW, et al. Ocul Immunol Inflamm. 2017 Oct;25(5):663-677. doi: 10.3109/09273948.2016.1158282. Epub 2016 May 18. Ocul Immunol Inflamm. 2017. PMID: 27192186 Review.

3

Intranasal Olopatadine-Mometasone in the Treatment of Seasonal Allergic Rhinitis.

Lim L, Lipari M, Kale-Pradhan P. Lim L, et al. Ann Pharmacother. 2023 May;57(5):570-578. doi: 10.1177/10600280221124230. Epub 2022 Sep 19. Ann Pharmacother. 2023. PMID: 36123818 Review.

4

Olopatadine/mometasone (Ryaltris) for allergic rhinitis.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2023 Jan 23;65(1668):12-14. doi: 10.58347/tml.2023.1668c. Med Lett Drugs Ther. 2023. PMID: 36651792 No abstract available.

5

Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.

Gonzalez-Estrada A, Reddy K, Dimov V, Eidelman F. Gonzalez-Estrada A, et al. Expert Opin Pharmacother. 2017 Aug;18(11):1137-1143. doi: 10.1080/14656566.2017.1346085. Epub 2017 Jul 9. Expert Opin Pharmacother. 2017. PMID: 28656804 Review.

6

Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate.

Ridolo E, Barone A, Nicoletta F, Paoletti G, Heffler E, Malvezzi L, Canonica GW. Ridolo E, et al. Expert Rev Clin Immunol. 2023 Jun;19(6):575-584. doi: 10.1080/1744666X.2023.2200165. Epub 2023 Apr 19. Expert Rev Clin Immunol. 2023. PMID: 37038974 Review.

7

Dupilumab-Induced Follicular Conjunctivitis.

Shen E, Xie K, Jwo K, Smith J, Mosaed S. Shen E, et al. Ocul Immunol Inflamm. 2019;27(8):1339-1341. doi: 10.1080/09273948.2018.1533567. Epub 2018 Oct 18. Ocul Immunol Inflamm. 2019. PMID: 30335586 No abstract available.

8

Efficacy and safety of twice-daily olopatadine-mometasone combination nasal spray (GSP301) in the treatment of allergic rhinitis: a systematic review and meta-analysis.

Chen R, Zheng D, Zhang Y, Sima G. Chen R, et al. Eur Arch Otorhinolaryngol. 2022 Apr;279(4):1691-1699. doi: 10.1007/s00405-021-07085-w. Epub 2021 Sep 30. Eur Arch Otorhinolaryngol. 2022. PMID: 34591150 Review.

9

Biomimetic contact lenses eluting olopatadine for allergic conjunctivitis.

González-Chomón C, Silva M, Concheiro A, Alvarez-Lorenzo C. González-Chomón C, et al. Acta Biomater. 2016 Sep 1;41:302-11. doi: 10.1016/j.actbio.2016.05.032. Epub 2016 May 21. Acta Biomater. 2016. PMID: 27221794

10

Intranasal combo: fixed-dose combination of mometasone furoate and olopatadine hydrochloride in therapeutic strategies for rhinosinusitis.

Samoliński B, Wojas O, Lipiec A, Krzych-Fałta E, Walkiewicz A, Borowicz J, Samoliński K. Samoliński B, et al. Otolaryngol Pol. 2023 Dec 4;77(6):43-50. doi: 10.5604/01.3001.0054.0941. Otolaryngol Pol. 2023. PMID: 38706259 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year